Literature DB >> 9476505

The hydroxypyridones: a class of antimycotics of its own.

H C Korting1, M Grundmann-Kollmann.   

Abstract

The hydroxypyridones chemically form a class of antimycotics not related to others. For a long time ciclopirox olamine has been the only compound to be used clinically. Recently, ciclopirox as a free acid and rilopirox have also been considered. The congeners are active against a broad spectrum of medically relevant fungi including dermatophytes, yeasts and moulds in vitro. According to investigations based on animal and in vivo models for fungal disease, this also applies in vivo. Low toxicity in the experimental animal has made topical applications in man possible. Clinical experience relates, in particular, to dermatophytosis and vaginal candidosis, but rarer conditions have also been investigated. High tolerability corresponds to efficacy in major dermatomycological conditions. Today, interest mainly focuses on ciclopirox lacquer for onychomycosis. Here as in general, the relative role of hydroxypyridones will have to be finally established in comparative trials.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9476505     DOI: 10.1111/j.1439-0507.1997.tb00227.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  6 in total

1.  Seborrheic dermatitis.

Authors:  Thomas Berk; Noah Scheinfeld
Journal:  P T       Date:  2010-06

Review 2.  Repositioning the Old Fungicide Ciclopirox for New Medical Uses.

Authors:  Tao Shen; Shile Huang
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

3.  Ciclopirox olamine treatment affects the expression pattern of Candida albicans genes encoding virulence factors, iron metabolism proteins, and drug resistance factors.

Authors:  Markus Niewerth; Donika Kunze; Michael Seibold; Martin Schaller; Hans Christian Korting; Bernhard Hube
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

Review 4.  Reposition of the Fungicide Ciclopirox for Cancer Treatment.

Authors:  Zhu Huang; Shile Huang
Journal:  Recent Pat Anticancer Drug Discov       Date:  2021       Impact factor: 3.038

5.  CPX Targeting DJ-1 Triggers ROS-induced Cell Death and Protective Autophagy in Colorectal Cancer.

Authors:  Jing Zhou; Lu Zhang; Meng Wang; Li Zhou; Xuping Feng; Linli Yu; Jiang Lan; Wei Gao; Chundong Zhang; Youquan Bu; Canhua Huang; Haiyuan Zhang; Yunlong Lei
Journal:  Theranostics       Date:  2019-07-28       Impact factor: 11.556

Review 6.  Treatment of superficial mycoses: review. Part II.

Authors:  Maria Fernanda Reis Gavazzoni Dias; Fred Bernardes-Filho; Maria Victória Pinto Quaresma-Santos; Adriana Gutstein da Fonseca Amorim; Regina Casz Schechtman; David Rubem Azulay
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.